Activation of both protein kinase A (PKA) type I and PKA type II isozymes is required for retinoid - induced maturation
of acute promyelocytic leukemia cells.
Retinoic acid — induced gene G (RIG - G), a gene originally identified in all - trans retinoic acid — treated NB4
acute promyelocytic leukemia cells, is also induced by IFNα in various hematopoietic and solid tumor cells.
The retinoic acid — induced gene G (RIG - G), also known as IFN - inducible gene 60, was originally identified in all - trans retinoic acid (ATRA)-- treated
NB4 acute promyelocytic leukemia (APL) cells (1) and plays an important role in cell growth inhibition through up - regulation of p21 and p27 (2).
With arsenic forcing the production of largely useless telomerase in cell lines that
simulate acute promyelocytic leukemia, the chromosomes in cancer cells fuse together, causing the cell death that helps fight the cancer.
Chen says that arecoline could be compared to arsenic, a form of which is used as a treatment
for acute promyelocytic leukemia, but is also linked to several types of cancer.
Arsenic trioxide (ATO) consolidation was well tolerated in pediatric patients
with acute promyelocytic leukemia (APL) and allowed for significant reductions in cumulative anthracycline doses, according to the results of the Children's Oncology Group AAML0631 trial published in the Journal of Clinical Oncology.
The news that Indianapolis Colts head coach Chuck Pagano has started chemotherapy for a rare form of cancer known
as acute promyelocytic leukemia (APL), while devastating to the team, city, and entire NFL community, comes with a silver lining: under the proper medical care and with a timely diagnosis, it is a treatable condition associated with a favorable prognosis.
These chromosomal translocations are common in various types of leukemia, so the researchers examined two types:
acute promyelocytic leukemia, which often carries a translocation between the PML and RARα genes; and acute myeloid leukemia, which can harbor a translocation between the MLL and AF9 genes.
Now a research team led by investigators in the Cancer Research Institute at Beth Israel Deaconess Medical Center (BIDMC), has identified an inhibitor of the Pin1 enzyme that can address both of these challenges in
acute promyelocytic leukemia (APL) and triple negative breast cancer.
Extremely Late Extramedullary Relapse of
Acute Promyelocytic Leukemia, Case Report and Review of the Literature
A combination of all - trans retinoic acid (ATRA) and arsenic trioxide resulted in outcomes «at least not inferior» to those achieved when ATRA was used in combination with idarubicin chemotherapy in newly diagnosed patients with non — high - risk,
acute promyelocytic leukemia.
Patients with a rare type of leukemia called
acute promyelocytic leukemia (APL) have better outcomes than most leukemias because they can be treated with a very effective drug that converts their cancer cells back to normal.
Arsenic trioxide consolidation was well tolerated in pediatric patients with
acute promyelocytic leukemia and allowed for significant reductions in cumulative anthracycline doses.